top of page

Our Team

IMMvention is powered by its experienced team with deep expertise in drug discovery and development across multiple therapeutic areas

Don-Haut.jpg
Don Haut, PhD
Executive Chair
MDCO-Logo-thumb.png
Aspect_fullcolourRGB.jpg
AskBio_Logo.jpg
Goyal-300x300.jpg
Anil Goyal, PhD
CEO and Co-founder
RiboLogo_4x.png
Millennium-Takeda.png
Serenex.jpg
matthew-gallovic-headshot.png
Matt Gallovic, PhD
Director of Research
baxter_4x.png
footer-unc-logo.png
Sarah Wise 6-8-21.jpg
Sarah Wise
Senior Scientist
purepng.com-gilead-logologobrand-logoiconslogos-251519940440brfzz.png
g62558image001.jpg

Consultants

Bridget-Martell.jpg

Bridget Martell, MD
Artizan Bio,
Kura Oncology

Chief Medical Officer

  • Grey LinkedIn Icon
Ryan Clark_edited.jpg

Ryan Clark, PhD
Inception, Amira

Head of Chemistry

  • Grey LinkedIn Icon
JR.png

John Reardon, PhD
Ribometrix, GSK

Head of R&D

  • Grey LinkedIn Icon
Dillberger.jpg

John Dillberger, PhD
Triangle Pharmaceuticals, GSK

Head of Toxicology

  • Grey LinkedIn Icon
SteveSmith.jpg

Steve Smith
UCB, Roche, Syntex

Head of DMPK

  • Grey LinkedIn Icon
Pratt-Headshot2.jpg

Ben Pratt, PhD
Vasa Therapeutics, Allergan

Head of CMC

  • Grey LinkedIn Icon
IMMvention-Background.png

Board of Directors

EXECUTIVE CHAIR
Don Haut, PhD, Independent
CEO and Director
Anil Goyal, PhD, IMMvention
DIRECTOR and CO-FOUNDER
Jenny Ting, PhD, UNC, Chapel Hill
DIRECTOR
Matt Cohen, PhD, Osage University Partners
DIRECTOR
Ben Scruggs, PhD, Hatteras Venture Partners
DIRECTOR
Natalia Novac, PhD, Delin Ventures
OBSERVER
Caroline Haegeman, PhD, Delin Ventures
OBSERVER
Harry Won, PhD, Osage University Partners
bottom of page